Abstract
At JADPRO Live 2025, Paula S. Kennedy-Newton, MSN, AGNP-C, discussed the underlying pathophysiology of neuroendocrine tumors (NETs), clinical presentation, diagnostic evaluation, the mechanisms of action and safety/efficacy data for NET therapies, and multidisciplinary care models to address the complex medical and psychosocial needs of patients living with NETs.
